Sophos Group announces a $3.9Bn acquisition bid from Thoma Bravo
By Akshay Kedari  Date: 2019-10-16

Sophos Group announces a $3.9Bn acquisition bid from Thoma Bravo

With growing cases of cyberattacks and hackings, the need for an effective cybersecurity application is imminent. Advancements in digitalization has indeed maximized the chances of cyberattacks. In order to tackle such rising cases, software companies are constantly rolling out new and updated security applications.

Companies in some cases are also expanding their horizon by means of acquiring other businesses that offer a better potential for strengthening their cybersecurity offerings. Sophos Group, a global provider of next-generation cybersecurity, has recently received such an offer from Thoma Bravo, an American private equity firm.

According to reliable sources, Thoma Bravo has offered to acquire Sophos for US$7.40 per share, valuing the deal at around US$3.9 billion. Sophos’ board of directors has also declared their plea to unanimously recommend the proposal to their firm’s shareholders.

For the uninitiated, Thoma Bravo is one of the prominent private equity firms that is dedicated towards software and services sector with more than 200 technology and software firms being acquired by the company that representing over $50 billion in value.

Moreover, Thoma Bravo is also known as one of the highly experienced and active private equity firms which is currently investing in technology and software companies, especially in cybersecurity.

Speaking on the move, Kris Hagerman, CEO, Sophos, said that the company is the front runner in driving innovative cybersecurity solutions and leveraging innovative abilities in machine learning, cloud, automation, APIs, managed threat response and more.

Adding further, Hagerman said that their company will maintain the execution of differentiated and highly effective strategy. Moreover, the company sees this deal as a compelling validation of Sophos along with its progress and position in the industry.

Incidentally, Sophos has also recently made some developments in cybersecurity platforms when it revealed that its Managed Threat Response (MTR), a fully managed threat detection, response and hunting service will now be accessible.

For the record, the service will offer organizations a committed 24/7 security team which would neutralize some of the most highly complex and sophisticated threats.

Source Credit: https://www.sophos.com/en-us/press-office/press-releases/2019/10/thoma-bravo-makes-offer-to-acquire-sophos.aspx

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...